TOS.TO - TSO3 Inc.

Toronto - Toronto Delayed Price. Currency in CAD
2.58
+0.05 (+1.98%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.53
Open2.51
Bid2.58 x 0
Ask2.60 x 0
Day's Range2.50 - 2.61
52 Week Range2.05 - 3.36
Volume49,068
Avg. Volume112,725
Market Cap239.564M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateNov 6, 2017 - Nov 10, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.41
  • CNW Group20 days ago

    TSO3 Announces the Death of Mr. Jean Lamarre

    QUEBEC CITY and MYRTLE BEACH , FL, Nov. 27, 2017 /CNW Telbec/ - TSO 3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of ...

  • PR Newswire20 days ago

    TSO3 Announces the Death of Mr. Jean Lamarre

    QUEBEC CITY and MYRTLE BEACH, FL, Nov. 27, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of Mr. Jean Lamarre, a member of the Board of Directors of TSO3.  Mr. Lamarre contributed sound and constructive counsel on TSO3's Board of Directors, and while leading TSO3's Human Resources Committee. Mr. Lamarre was a pillar of the Canadian business community, holding several board positions, including the position of Board Chair for SEMAFO, and various other positions of significant responsibility with Groupe Lavalin and numerous other organizations.

  • PR Newswirelast month

    TSO3 Provides Duodenoscope Regulatory Filing Update

    QUEBEC CITY and MYRTLE BEACH, SC, Nov. 16, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to the recent request for additional information (AI), from the U.S. Food and Drug Administration. This information is in support of the Company's submission to extend claims of its innovative STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes. The Company's response includes a summary of results from tests evaluating the effect of TSO3's sterilization process on specific features incorporated in the design of identified scopes, as well as additional labeling targeted at a selected duodenoscope.

  • CNW Grouplast month

    TSO3 Provides Duodenoscope Regulatory Filing Update

    QUEBEC CITY and MYRTLE BEACH, SC, Nov. 16, 2017 /CNW Telbec/ - TSO3 Inc. (TSX:TOS.TO - News), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to the recent request for additional information (AI), from the U.S. Food and Drug Administration. This information is in support of the Company's submission to extend claims of its innovative STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes. The Company's response includes a summary of results from tests evaluating the effect of TSO3's sterilization process on specific features incorporated in the design of identified scopes, as well as additional labeling targeted at a selected duodenoscope.

  • PR Newswirelast month

    TSO3 Reports Record Third Quarter 2017 Results

    QUEBEC CITY and MYRTLE BEACH, SC , Nov. 6, 2017 /PRNewswire/ - TSO 3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for ...

  • CNW Grouplast month

    TSO3 Reports Record Third Quarter 2017 Results

    QUEBEC CITY and MYRTLE BEACH, SC , Nov. 6, 2017 /CNW Telbec/ - TSO 3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, reported financial results for ...

  • CNW Group2 months ago

    TSO3 Sets Third Quarter Earnings Call for Tuesday, November 7, 2017 at 8:30 a.m. EST

    QUÉBEC CITY and MYRTLE BEACH, SC, Oct. 25, 2017 /CNW Telbec/ - TSO3 Inc. (TSX:TOS.TO - News), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Tuesday, November 7, 2017, to discuss its financial results for the third quarter ended September 30, 2017. Financial results will be issued in a press release prior to the call.

  • PR Newswire2 months ago

    TSO3 Duodenoscope Sterilization Technology to be Featured at the 18th World Federation for Hospital Sterilisation Sciences (WFHSS) Congress in Bonn, Germany

    Mr. Csapo's presentation will discuss VGH's use of the STERIZONE® VP4 Sterilizer to sterilize duodenoscopes used in Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures and how they have successfully transitioned to full terminal sterilization of their duodenoscopes.

  • CNW Group2 months ago

    TSO3 Duodenoscope Sterilization Technology to be Featured at the 18th World Federation for Hospital Sterilisation Sciences (WFHSS) Congress in Bonn, Germany

    Mr. Csapo's presentation will discuss VGH's use of the STERIZONE® VP4 Sterilizer to sterilize duodenoscopes used in Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures and how they have successfully transitioned to full terminal sterilization of their duodenoscopes.